Quercetin in prostate cancer: Chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review).

Abstract:

:The morbidity and mortality of prostate cancer have been increasing recently, and the comprehensive treatment for prostate cancer is unable to achieve satisfactory outcomes. Quercetin is a natural flavonoid compound that has attracted increased interest and attention due to its anticancer activity. In vitro and in vivo studies have verified that quercetin effectively inhibits prostate cancer via various mechanisms. Clinical trails concerning the pharmacokinetics and application of quercetin in humans have also obtained promising results. Meanwhile, epidemiologic studies have demonstrated a negative association between quercetin intake and prostate cancer incidence and have suggested a chemopreventive effect of quercetin on prostate cancer that has been exhibited in animal experiments. The main issue concerning quercetin utilization is its low bioavailability. Therefore, solutions to the issues concerning its use such as alteration of the molecular structure and combination therapy are in the exploratory stage. In the present review, the most important aspects of chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential of quercetin in prostate cancer are summarized.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yang F,Song L,Wang H,Wang J,Xu Z,Xing N

doi

10.3892/or.2015.3886

subject

Has Abstract

pub_date

2015-06-01 00:00:00

pages

2659-68

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

33

pub_type

杂志文章,评审
  • Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.

    abstract::Transforming growth factor-β1 (TGF-β1) signaling has been shown to play a critical role in the development of epithelial-mesenchymal transition (EMT). PAI-1 is one of the most important target genes in the TGF-β/Smad signaling pathway, which can hinder the degradation of ECM composition and may promote cell invasion a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5292

    authors: Wang X,Liu C,Wang J,Fan Y,Wang Z,Wang Y

    更新日期:2017-02-01 00:00:00

  • miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.

    abstract::MicroRNAs (miRNAs) play important roles in the the gene regulation of carcinogenesis including breast cancer. miR‑519d has been studied in various types of cancer, but its role in breast cancer remains unclear. In the present study, we investigated the expression and biological function of miR-519d in breast cancer. U...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4160

    authors: Deng X,Zhao Y,Wang B

    更新日期:2015-10-01 00:00:00

  • Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

    abstract::Cancer represents a significant challenge for humankind, as early diagnosis and treatment are difficult to achieve. To systemically investigate the effect of sex, body mass index (BMI) and age on cancer incidence and prognosis, the data from 14,504 cases of cancer were downloaded from The Cancer Genome Atlas (TCGA). B...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6529

    authors: Huang X,Shu C,Chen L,Yao B

    更新日期:2018-09-01 00:00:00

  • Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.

    abstract::The mechanisms leading to squamous cell carcinoma of head and neck (SCCHN) metastasis are not fully understood. Although evidence shows that the chemokine receptor 7 (CCR7) and its ligand CCL19 may regulate tumor dissemination, their role is not clearly defined in SCCHN. Matrix metalloproteinases break consisting of t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3242

    authors: Guo N,Liu F,Yang L,Huang J,Ding X,Sun C

    更新日期:2014-08-01 00:00:00

  • miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.

    abstract::Recent studies have shown that miRNAs have potent abilities to activate gene expression by targeting promoter elements, a phenomenon known as RNA activation (RNAa). In the present study, we identified a new endogenous miR-3619-5p which was decreased in prostate cancer tissues and cells compared to corresponding normal...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5250

    authors: Li S,Wang C,Yu X,Wu H,Hu J,Wang S,Ye Z

    更新日期:2017-01-01 00:00:00

  • Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.

    abstract::Muscle atrophy F-Box (MAFbx)/atrogin-1 and muscle ring-finger-1 (MuRF-1) have been identified as two muscle-specific E3 ubiquitin ligases that are highly expressed in skeletal muscle during muscle atrophy. However, the role of muscle-specific E3 ubiquitin ligases during the process of muscle atrophy of cancer cachexia...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3845

    authors: Yuan L,Han J,Meng Q,Xi Q,Zhuang Q,Jiang Y,Han Y,Zhang B,Fang J,Wu G

    更新日期:2015-05-01 00:00:00

  • Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab.

    abstract::The overexpression of EGFR and/or HER-2 is associated with tumor cell resistance to chemotherapy, radiotherapy, disease progression and poor prognosis in patients with a variety of malignant tumors. Treatment combining the EGFR-targeting drug, gefitinib (ZD1839, Iressa) with the HER-2-targeting drug, trastuzumab (Herc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kondo N,Ishiguro Y,Kimura M,Sano D,Fujita K,Sakakibara A,Taguchi T,Toth G,Matsuda H,Tsukuda M

    更新日期:2008-08-01 00:00:00

  • Is survival following post-operative radiotherapy in pN1-non-small cell lung cancer reduced? Results of a multivariate analysis.

    abstract::Prognostic factors and the role of post-operative radiotherapy (PORT) in patients with pN1 nodal stage following surgery for NSCLC were identified. The clinical course of 211 patients with pN1 nodal involvement following thoracic surgery were reviewed, 97 of them received PORT. Multi-variate survival analysis with res...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Willner J,Wiens V,Jachmann M,Haubitz I,Flentje M

    更新日期:2004-09-01 00:00:00

  • Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey.

    abstract::No information is currently available regarding pancreatic cancer (PC) pattern of care in Italy. In the present study, a nationwide survey using a questionnaire was performed to enquire the local standards for PC diagnosis and radiotherapy treatment. Fifty-seven percent of 140 Italian centres completed questionnaire. ...

    journal_title:Oncology reports

    pub_type: 杂志文章,多中心研究

    doi:10.3892/or.2015.3955

    authors: Macchia G,Sainato A,Talamini R,Boz G,Bacigalupo A,Caravatta L,Fiore M,Friso ML,Fusco V,Lupattelli M,Mantello G,Mattiucci GC,Slim N,Sciacero P,Turri L,Valentini V,Morganti AG,Genovesi D

    更新日期:2015-07-01 00:00:00

  • Pentoxifylline promotes development of murine colon adenocarcinoma-derived metastatic tumors in liver.

    abstract::Pentoxifylline is commonly used in the treatment of peripheral vascular diseases. It improves microcirculatory flow and tissue perfusion. Moreover, pentoxifylline displays some immunomodulatory properties that presumably might affect the anticancer response. Therefore, the aim of the present study was to evaluate the ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Grzela T,Lazarczyk M,Niderla J,Golab J,Lazarczyk MA,Skopinski P

    更新日期:2003-11-01 00:00:00

  • Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a rare but severe primary hemopoietic system tumor of childhood, most frequent in children 4 years and younger. There are currently no specific anticancer therapies targeting JMML, and the underlying gene expression changes have not been revealed. To define molecular targets ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6709

    authors: Zhao W,Wang L,Yu Y

    更新日期:2018-12-01 00:00:00

  • Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma.

    abstract::Galectin-3 is a soluble endogenous lectin in vertebrates and is implicated in a variety of biological functions, including tumor cell adhesion, proliferation, differentiation, apoptosis, cancer progression and metastasis. In the present study, we analyzed the role of galectin-3 in apoptosis in human malignant lymphoma...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Suzuki O,Abe M

    更新日期:2008-03-01 00:00:00

  • DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.

    abstract::DNA damage sensor proteins are recognized as upstream components of the DNA damage checkpoint signaling pathway and are required for cell cycle control and the induction of apoptosis. hRad9 plays an important role as an upstream regulator of checkpoint signaling. In our previous studies, we confirmed the significant a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yuki T,Maniwa Y,Doi T,Okada K,Nishio W,Hayashi Y,Okita Y

    更新日期:2008-11-01 00:00:00

  • Caspase-dependent mitochondrial apoptotic pathway is involved in astilbin-mediated cytotoxicity in breast carcinoma cells.

    abstract::Astilbin exhibits several pharmacological activities, including hypoglycemic, anti-oxidant and anti-inflammatory properties. The aim of the present study was to investigate the pro-apoptotic activities of astilbin on breast cancer in cells and mice. It was demonstrated that astilbin significantly reduced the cell viab...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6602

    authors: Sun X,Zhang H,Zhang Y,Yang Q,Zhao S

    更新日期:2018-10-01 00:00:00

  • High‑throughput and continuous flow isolation of rare circulating tumor cells and clusters in gastric cancer from human whole blood samples using electromagnetic vibration‑based filtration.

    abstract::Circulating tumor cells (CTCs) or CTC clusters are considered as suitable and relevant targets for liquid biopsy as they more accurately indicate cancer progression, the therapeutic effects of treatment and allows for monitoring of cancer metastasis in real‑time. Among the various methods for isolating CTCs, size‑base...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7567

    authors: Xiang A,Xue M,Ren F,Wang L,Ye Z,Li D,Ji Q,Ji G,Lu Z

    更新日期:2020-06-01 00:00:00

  • Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathways.

    abstract::Membrane-associated RING-CH (MARCH) belongs to the family of RING-CH type E3 ubiquitin ligases. MARCH1 ubiquitinates and downregulates MHC class II expression in APCs and targets major players of the immune system. However, the role of MARCH1 in ovarian cancer has not been elucidated. The present study investigated th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5076

    authors: Meng Y,Hu J,Chen Y,Yu T,Hu L

    更新日期:2016-11-01 00:00:00

  • High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.

    abstract::Human papillomavirus (HPV) L1 capsid protein is only produced during a productive HPV infection at the end of the natural viral life cycle and is a major target of the immune response in women with HPV-related squamous intraepithelial lesions. We evaluated the usefulness of L1 detection by immunocytochemistry in high-...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2538

    authors: Norman I,Hjerpe A,Andersson S

    更新日期:2013-08-01 00:00:00

  • PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.

    abstract::PSMB4, proteasome subunit β4, is a member of the ubiquitin-proteasome family, and is elevated in a variety of malignancies. However, the expression level and related mechanism of PSMB4 in breast cancer remains unclear. Therefore, the present study investigated the expression level of PSMB4 in eight pairs of breast can...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6588

    authors: Wang H,He Z,Xia L,Zhang W,Xu L,Yue X,Ru X,Xu Y

    更新日期:2018-10-01 00:00:00

  • Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.

    abstract::The present study was carried out to investigate the clinical significance of TMPRSS3 and TNFRSF11B in breast cancer. Thus, the expression levels of TMPRSS3 and TNFRSF11B and the correlation with prognosis in patients with breast cancer were analyzed in silico using gene microarray and hierarchical clustering analysis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5449

    authors: Luo P,Lu G,Fan LL,Zhong X,Yang H,Xie R,Lv Z,Lv QZ,Fu D,Yang LX,Ma Y

    更新日期:2017-04-01 00:00:00

  • Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.

    abstract::The pre-S mutant LHBs, especially the pre-S2 type, is believed to be crucial in HBV-associated hepatocellular carcinogenesis. However, the mechanism of HBV-induced hepatocellular carcinoma is not fully understood. To identify the mechanism, pre-S2 LHBs-interacting proteins were stud...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1489

    authors: Lei Y,Liu H,Yang Y,Wang X,Ren N,Li B,Liu S,Cheng J,Fu X,Zhang J

    更新日期:2012-01-01 00:00:00

  • Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.

    abstract::Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. Tumor specific cellular and humoral immunotherapy may be a viable approach for the treatment of HCC. This study investigated specific inhibitory and cytotoxic effects on hepatocellular carcinoma (HCC) induced by the peptide, designated HBc Delt...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kong J,Diao Z,Deng X,Zhong H,Yao W,Hu X

    更新日期:2007-07-01 00:00:00

  • Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.

    abstract::MHC class I-related chain molecules A and B (MICA and B) expressed on the cell-surface of tumor cells are ligands for an activating receptor, NKG2D, expressed on natural killer (NK) cells and stimulate the NK cell-mediated cytotoxicity. On the other hand, the soluble form of MICA and B produced by proteolytic cleavage...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00001026

    authors: Yamanegi K,Yamane J,Kobayashi K,Kato-Kogoe N,Ohyama H,Nakasho K,Yamada N,Hata M,Nishioka T,Fukunaga S,Futani H,Okamura H,Terada N

    更新日期:2010-12-01 00:00:00

  • Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.

    abstract::One of the dose-limiting toxicities of irinotecan (CPT-11) is delayed-onset diarrhea, which is the greatest barrier to treatment with CPT-11-containing regimens. CPT-11 is converted to its active metabolite, SN-38, which is conjugated by hepatic uridine diphosphate glucuronosyl transferase to SN-38 glucuronide (SN-38G...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamamoto M,Kurita A,Asahara T,Takakura A,Katono K,Iwasaki M,Ryuge S,Wada M,Onoda S,Yanaihara T,Yokoba M,Mitsufuji H,Nishii Y,Fukui T,Masuda N

    更新日期:2008-10-01 00:00:00

  • Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.

    abstract::Endometrial cancer is a common gynecological malignancy with a good prognosis in early stages of the disease. The CpG island in the promoter region of tumor-suppressor genes are frequently methylated in various types of human cancers. In the present study, we examined the methylation status of the GSTP1, CDH1 and RASS...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2752

    authors: Fiolka R,Zubor P,Janusicova V,Visnovsky J,Mendelova A,Kajo K,Lasabova Z,Plank L,Danko J

    更新日期:2013-12-01 00:00:00

  • The effects of the Wnt/β‑catenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.

    abstract::The molecular mechanisms underlying the biological effects of carbon ions are unclear. The aim of this study was to explore the Wnt/β‑catenin pathway in regulating carbon ion (12C6+) radiation‑induced cellular toxicity. HLY78 is a Wnt‑specific small molecular modulator, whose effects on 12C6+ radiation‑induced damage ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7581

    authors: Si J,Zhang J,Gan L,Guo M,Xie Y,Di C,Sun C,Wang F,Yan J,Zhang H

    更新日期:2020-07-01 00:00:00

  • Tannic acid attenuates hepatic oxidative stress, apoptosis and inflammation by activating the Keap1‑Nrf2/ARE signaling pathway in arsenic trioxide‑toxicated rats.

    abstract::The present study was performed to investigate the protective effects of tannic acid (TA) on liver injury induced by arsenic trioxide (ATO) and to elucidate the mechanism involved as related to the Kelch‑like ECH‑associated protein 1 (Keap1)‑nuclear factor erythroid 2‑related factor 2 (Nrf2)/antioxidant response eleme...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7764

    authors: Li M,Liu P,Xue Y,Liang Y,Shi J,Han X,Zhang J,Chu X,Chu L

    更新日期:2020-11-01 00:00:00

  • Expression of p53 and DR5 in normal and malignant tissues of colorectal cancer: correlation with advanced stages.

    abstract::Apoptosis has to be drastically controlled in organs with important cell turnover such as the colon. Deregulation of this process is often present in tumor progression. Tissues of 82 patients treated for colorectal cancer (CRC) were analyzed using antibodies against AIF, p53, DR4, DR5, cleaved caspase-3 and the TUNEL ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1404

    authors: Perraud A,Akil H,Nouaille M,Petit D,Labrousse F,Jauberteau MO,Mathonnet M

    更新日期:2011-11-01 00:00:00

  • Frequent CYP1A1 expression in gastric cancers and their related lesions.

    abstract::CYP1A1 expression in various tissues of 43 gastric cancer cases was analyzed with frozen tissue array-based immunohistochemical staining (IHC), RT-PCR, Western blot analysis and EROD (7-ethoxyresourfin-O-deethylase) assay. CYP1A1 was detected immunohistochemically in 86% (37/43) of gastric cancers, in both 57% (4/7) o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhang KL,Ma JX,Chen XY,Sun Y,Kong QY,Liu J,Li H

    更新日期:2004-12-01 00:00:00

  • Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.

    abstract::Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor and its activation has been associated with the pathogenetic progress in certain cancers. Toll-like receptor 4 (TLR4), one member of Toll-like receptors family, is mainly contributed to the innate immune response. However, recent studies have shown t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1077

    authors: Zhou B,Zhou H,Ling S,Guo D,Yan Y,Zhou F,Wu Y

    更新日期:2011-02-01 00:00:00

  • Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.

    abstract::Tanshinone IIA is known to induce apoptosis in several types of cancer cells. However, little is known about its activity in chemoresistant cells. The aim of this study was to investigate the anticancer properties of tanshinone IIA in cisplatin-resistant human ovarian cancer COC1/DDP cells in vitro. We used a variety ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1107

    authors: Jiao JW,Wen F

    更新日期:2011-03-01 00:00:00